Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of the Automatized and the Optimized Carbon Monoxid Rebreathing Protocol Determining Hemoglobinmass With Capillary and Venous Blood Sampling

NCT04189250 is registered in ClinicalTrials.gov with Swiss Federal Institute of Sport Magglingen as lead sponsor.

NCT NCT04189250
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04189250 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of the Automatized and the Optimized Carbon Monoxid Rebreathing Protocol Determining Hemoglobinmass With Capillary and Venous Blood Sampling
Lead sponsor
Swiss Federal Institute of Sport Magglingen
Phase
Not applicable
Overall status
Unknown status
Start date
January 20, 2020
Completion date
August 1, 2020
Enrollment
31 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hemoglobins